REGN Expected Earnings Move
Regeneron Pharmaceuticals, Inc. · Updated 2026-10-17 after market close
As of 2026-10-17, the options market prices an expected move of about ±6.4% for Regeneron Pharmaceuticals, Inc. (REGN) around its 2026-10-30 earnings report. REGN's median reaction across its last 8 reports is 6.2%. Source: hirethequant.com.
Next report
2026-10-30
13 days away
Options-implied move
±6.4%
ATM straddle, nearest expiry
The market is pricing this report at 1.03x REGN's own historical median reaction.
Last 8 earnings reactions
Close-to-close move around each report date. Red bars exceeded today's implied move.
| Report date | Reaction | Relative size |
|---|
| 2026-07-30 | 6.2% |
|
| 2026-04-29 | 6.2% |
|
| 2026-01-30 | 1.8% |
|
| 2025-10-28 | 11.8% |
|
| 2025-08-01 | 2.5% |
|
| 2025-04-29 | 6.9% |
|
| 2025-02-04 | 4.5% |
|
| 2024-10-31 | 9.2% |
|
See every stock reporting this week, scored →
The free Weekly Earnings Desk ranks the week's reports with signal-strength scores. Free account, no credit card needed.
Behind the free desk: nine scored desks (value, momentum, options, dividends, crypto) from $14.99/mo at hirethequant.com.
Cite this page: hirethequant.com/earnings/regn/ · data updated nightly by hirethequant
Provided for research and education only; not investment advice or a recommendation to buy or sell any security. Implied move is derived from listed option prices and reflects market expectations, not a prediction. Past earnings reactions do not determine future results. © 2026 hirethequant, a Matthews Cloud Solutions product.